AbbVie Q2 earnings preview: analysts eye immunology growth, pipeline

July 30, 2026 11:30 PM

Investing.com-- AbbVie is expected to face investor scrutiny over the durability of its immunology franchise and the strength of newer ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found